Selected article for: "age distribution and high risk"

Author: Xiaofan Lu; Yang Wang; Taige Chen; Yongsheng Li; Jun Wang; Fangrong Yan
Title: Classification of COVID-19 in intensive care patients: towards rational and effective clinical triage
  • Document date: 2020_4_11
  • ID: 6cr9h7no_15
    Snippet: This report, to our knowledge, is the first attempt of dealing with classification of in intensive care patients. The four types are prognosis-related and present a stepwise distribution in age, respiratory condition and inflammatory markers, suggesting the prognostic efficacy of these indicators. The specificity of symptoms does not appear to be strong, but gastrointestinal response (e.g., diarrhea) needs vigilance (4) . Unexpectedly, hypertensi.....
    Document: This report, to our knowledge, is the first attempt of dealing with classification of in intensive care patients. The four types are prognosis-related and present a stepwise distribution in age, respiratory condition and inflammatory markers, suggesting the prognostic efficacy of these indicators. The specificity of symptoms does not appear to be strong, but gastrointestinal response (e.g., diarrhea) needs vigilance (4) . Unexpectedly, hypertension is more evenly distributed, which contradicts previous study indicating hypertensive with COVID-19 was more likely to be in a high risk of mortality (5) .

    Search related documents:
    Co phrase search for related documents
    • care patient and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • care patient and intensive care patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • care patient and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • care patient and respiratory condition: 1, 2, 3, 4, 5, 6, 7, 8
    • high risk and inflammatory marker: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • high risk and intensive care patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high risk and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high risk and prognostic efficacy: 1, 2
    • high risk and respiratory condition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • inflammatory marker and prognostic efficacy: 1
    • inflammatory marker and respiratory condition: 1, 2
    • inflammatory marker and stepwise distribution: 1
    • inflammatory marker respiratory condition and respiratory condition: 1
    • intensive care patient and respiratory condition: 1
    • prognostic efficacy and respiratory condition: 1
    • prognostic efficacy and stepwise distribution: 1